当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析

尔康制药

(300267)

  

流通市值:34.14亿  总市值:49.50亿
流通股本:14.22亿   总股本:20.63亿

尔康制药(300267)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.24亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益506680.32万元,未分配利润178276.45万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产552439.66万元,负债45759.34万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入1,445,366,591.951,050,160,519.66546,925,468.791,870,540,810.78
营业总成本1,458,628,102.51,034,277,548.73525,219,144.991,882,005,367.94
营业利润35,816,355.548,595,924.9318,917,822.6413,779,914.24
利润总额41,306,414.7553,666,396.9220,861,989.1617,354,194.38
净利润23,962,311.3541,118,711.820,455,494.1636,890,803.05
其他综合收益53,865,324.8664,227,558.01-22,816,079.17149,215,469.71
综合收益总额77,827,636.21105,346,269.81-2,360,585.01186,106,272.76
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计1,694,957,760.51,758,508,679.431,863,153,004.682,091,204,367.56
非流动资产合计3,829,438,807.373,826,248,437.733,737,184,760.133,764,455,015.4
资产总计5,524,396,567.875,584,757,117.165,600,337,764.815,855,659,382.96
流动负债合计388,376,633.15416,083,873.98473,804,742.44725,433,270.44
非流动负债合计69,216,768.5474,219,431.7277,828,099.2879,134,934.94
负债合计457,593,401.69490,303,305.7551,632,841.72804,568,205.38
归属于母公司股东权益合计5,082,273,045.395,104,552,312.195,054,292,171.315,050,820,622.25
股东权益合计5,066,803,166.185,094,453,811.465,048,704,923.095,051,091,177.58
负债和股东权益合计5,524,396,567.875,584,757,117.165,600,337,764.815,855,659,382.96
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计1,784,411,604.431,201,620,704.92610,092,589.462,289,816,187.02
经营活动现金流出小计1,807,044,692.691,150,269,481.18733,296,364.822,008,796,244.54
经营活动产生的现金流量净额-22,633,088.2651,351,223.74-123,203,775.36281,019,942.48
投资活动现金流入小计824,286,824.22664,516,241.68548,552,593.261,502,906,339.3
投资活动现金流出小计921,044,133.51703,590,297.68597,787,680.321,761,490,567.19
投资活动产生的现金流量净额-96,757,309.29-39,074,056-49,235,087.06-258,584,227.89
筹资活动现金流入小计115,550,895.1115,550,895.165,550,895.1376,749,600
筹资活动现金流出小计351,621,151.95350,507,683.77235,952,871.58386,117,813.33
筹资活动产生的现金流量净额-236,070,256.85-234,956,788.67-170,401,976.48-9,368,213.33
汇率变动对现金及现金等价物的影响-2,332,621.9891,685.03-2,864,853.7518,302,152.45
现金及现金等价物净增加额-357,793,276.38-222,587,935.9-345,705,692.6531,369,653.71
期末现金及现金等价物余额275,147,122.98410,352,463.46287,234,706.71632,940,399.36
TOP↑